Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment

PLoS ONE - United States
doi 10.1371/journal.pone.0032879
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Cost-Effectiveness of Teriparatide Compared With Alendronate and Risedronate for the Treatment of Postmenopausal Osteoporosis Patients in Iran

Medical Journal of the Islamic Republic of Iran
Medicine
2017English

The Cost and Cost-Effectiveness of Scaling Up Screening and Treatment of Syphilis in Pregnancy: A Model

PLoS ONE
Multidisciplinary
2014English

Greater First Year Effectiveness Drives Favorable Cost-Effectiveness of Brand Risedronate Versus Generic or Brand Alendronate: Modeled Canadian Analysis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2007English

Cost and Cost-Effectiveness of Obesity Treatment: A Mini Review

Health and Primary Care
2019English

The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2011English

What Determines the Cost-Effectiveness of Diabetes Screening?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Cost Effectiveness of Colorectal Cancer Screening Strategies

Cancer Control
MedicineOncologyHematology
2015English

PMS71 Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Cost-Effectiveness of the Norwegian Breast Cancer Screening Program

International Journal of Cancer
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy